Abbott issued a medical device correction for some of its glucose sensors after internal testing found that some sensors may ...

Abbott Laboratories said on Monday it has begun a correction in the United States for certain FreeStyle ​Libre 3 and ...

Abbott has launched an effort to replace some of its FreeStyle Libre 3 continuous glucose monitors—following reports of hundreds of injuries and seven deaths worldwide—after some sensors | A ...

A Key Step In Diabetes Management. Diabetes is a chronic condition that affects millions of people worldwide, and managing ...

The SMBG devices market presents opportunities in integrating with mobile apps for real-time tracking, embracing ...

Sargassum seaweed is creating major new obstacles for sea turtle hatchlings, drastically slowing their crawl to the ocean and ...

Campaigns are in full swing to mark World Diabetes Day on November 14. World Diabetes Day was established by the International Diabetes Federation (IDF) and the World Health Organization (WHO) to ...

When Russians look back at 2025, they might remember it as the year when the government took even tighter control of the ...

The West African nation faces a rising caseload, with the disease is increasingly affecting young Nigerians. This challenges ...

According to Precedence Research, the global glucose biosensors market size will grow from USD 10.71 billion in 2025 to nearly USD 23.08 billion by 2034, with an expected CAGR of 8.91% from 2025 to ...

Newsweek is committed to journalism that is factual and fair. Our Fairness Meter allows readers to hold us accountable by rating an article's fairness in one of five ways. Step In. Stand Up. Shape The ...

Abbott (NYSE:ABT) announced today that it issued a device correction for certain FreeStyle Libre 3 and Libre 3 Plus sensors ...